Details

Last Funding Type

Seed

Last Funding Money Raised

$1M

Industries

Biotechnology,Health Care,Life Science,Medical

Founded date

Jan 1, 2017

Number Of Employee

1 - 10

Operating Status

Active

RoverMed develops precision targeted drug delivery technology aimed at delivering life saving drugs to the most challenging diseases in hard to reach places in the body.


RoverMed has developed targeted, twenty nanometer nanocapsule technology capable of reaching the most challenging disease sites and delivering cargo – intact – into the nucleus of target cells, regardless of where these cells are located in the body.

RoverMed’s nanocapsule technology has been proven, through years of intensive research and development, by Minnesota-based GeneSegues Therapeutics. A precision target drug delivery platform has been developed initially for solid tumor cancers of the head and neck, prostate, and colon.

RoverMed is now applying this technology toward a broader spectrum of treatment applications, in partnership with larger drug developers, in order to expand the acceptance, use and impact on a host of new, exciting applications. Our business model includes partnering our drug delivery technology with our partner's drugs to advance novel therapeutics aimed at treating some of the most challenging diseases that are not well served by traditional therapeutic options.